BackSabra Healthcare REIT Overview
Sabra Healthcare REIT Inc

Sabra Healthcare REIT Target Price

Analysts' average 12-month price target for Sabra Healthcare REIT is $22.

Get informed when a big investor buys or sells

+ Follow

Share Price

$19.16

Average Target Price

$22.0014.8% upside

7 analysts in the last 4 months

High: $25 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-31Mizuho Securities$219.6% upsideOpen
2026-08-31BarclaysRichard Hightower$2320% upsideOpen
2026-07-22UBS$2530.5% upsideOpen
2026-07-22Robert W. BairdWesley Golladay$2320% upsideOpen
2026-07-08Truist Financial$2214.8% upsideOpen
2026-07-07Barclays$219.6% upsideOpen
2026-06-18UBS$190.8% downsideOpen
2026-05-21Scotiabank$2214.8% upsideOpen
2026-05-13UBSMichael Goldsmith$2214.8% upsideOpen
2026-05-11Cantor FitzgeraldRichard Anderson$2214.8% upsideOpen
2026-02-19UBSMichael Goldsmith$219.6% upsideOpen
2026-02-17Cantor FitzgeraldRichard Anderson$219.6% upsideOpen
2026-01-20Truist FinancialMichael Lewis$219.6% upsideOpen
2025-12-15JefferiesJoe Dickstein$2214.8% upsideOpen
2025-11-25Wells Fargo$219.6% upsideOpen
2025-10-21Wells Fargo$204.4% upsideOpen
2025-10-17National Bank$2214.8% upsideOpen
2025-10-01Cantor FitzgeraldRichard Anderson$204.4% upsideOpen
2025-09-02Truist Financial$204.4% upsideOpen
2024-09-12CitigroupNicholas Joseph$204.4% upsideOpen
2024-09-03Truist FinancialMichael Lewis$186.1% downsideOpen
2024-06-21Robert W. BairdDavid Rodgers$1616.5% downsideOpen
2024-05-15ScotiabankNicholas Yulico$1521.7% downsideOpen
2023-05-31Credit SuisseOmotayo Okusanya$1332.2% downsideOpen
2021-12-27Truist FinancialMichael R Lewis$1616.5% downsideOpen
2021-08-24JefferiesJonathan Petersen$190.8% downsideOpen
2021-05-04Capital One FinancialDaniel Bernstein$204.4% upsideOpen

Sabra Healthcare REIT (SBRA) FAQ

As of the most recent data, SBRA shows a target price of $22. Scroll down for historical charts and peer comparison views.

If Sabra Healthcare REIT moved to the average analyst target of $22, shares would be roughly 14.8% higher than $19.16. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Sabra Healthcare REIT's earnings trajectory.

Besides this target price page, Stockcircle has Sabra Healthcare REIT's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $22) with ownership activity and broader fundamentals.

Sabra Healthcare REIT's target price is $22; compare it with other Finance names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.